-
Business
Korea’s first homegrown GLP-1: Can Hanmi’s Eppe undercut Mounjaro and Wegovy?
Hanmi Pharmaceutical’s Eppe is poised to challenge Wegovy and Mounjaro in Korea’s fast-growing obesity drug market, with price emerging as a potentially decisive advantage. The homegrown glucagon-like
-
Sports
A familiar 3rd-place finish for S. Korea, but fewer golds, biggest gap yet with Japan
Korea won gold medals in 22 sports, two more than at Hangzhou, meaning its champions came from a broader range of sports despite the decline in its overall gold tally.
-
National
‘I don’t go to Cornell’: Online hunt for Korean defendant spills over to namesakes
As speculation surrounding a Korean defendant in the Cornell University sexual assault lawsuit spreads across social media, unrelated people who share his name are being wrongly identified and subject
- [Graphic News] Nuri rocket set for fifth launch
- [Miao Yanliang] Will AI reverse renminbi’s rise?
- [Grace Kao] Reflections on RM's exhibit at SFMOMA
- [Editorial] Outdated privilege
- LG wins 5GW AI cooling deal in North America
- Eric Nam to release fourth LP on Oct. 16